Independent US Healthcare Provider Directory & Public Medical Database Patient Guides

Dr. Robert Alan Clark , MD

Dermatology • Fairhope, AL

Active NPI 1548249436 Individual Practitioner Male Practitioner
Practice location in NPPES

7550 Assunta Ct
Fairhope, AL 365323069

Call 2519284944 Location details and other listings
Medical Disclaimer

This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.

Practice Location & Contact Primary Location

Practice Address

7550 Assunta Ct

Fairhope, AL 365323069

Telephone 2519284944
Fax 2519282086
Organization at the Same NPPES Address or Phone
Bay Shore Dermatology, Pc Facility NPI 1316011398

Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.

Medicare patients

404 people with Original Medicare in 2024

Different Original Medicare patients in 2024; counts below 11 are hidden; this does not show availability or quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.

Medicare-allowed amount

About $133,998 in 2024

The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.

What this does not show: Medicare-allowed amount

This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

Paid by Medicare

About $94,443 in 2024

The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.

What this does not show: Paid by Medicare

This is not the clinician's income and not a measure of quality.

Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.

30-day fills

521 standardized 30-day fills in 2024

CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.

What this does not show: 30-day fills

It is not a count of patients and not a measure of quality.

Part D drug cost

$10,228 in 2024

The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.

What this does not show: Part D drug cost

A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.

Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.

Open Payments general payments, program year 2025

All general payments: $129.75 across 6 records.

By nature of payment

  • Food and Beverage: $129.75 across 6 records.

Reporting-company totals

  • ABBVIE INC.: $62.57 across 3 records.
  • Bristol Myers Squibb Company: $43.50 across 2 records.
  • Pfizer Inc.: $23.68 across 1 record.

A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.

See the full table

Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).

Guide: How to read an Open Payments record

NPI first issued

2006

The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.

What this does not show: NPI first issued

NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.

Source: CMS NPPES NPI Registry.

Medicare assignment not listed

CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.

Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.

Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”

Guide: What Medicare assignment means

No telehealth indicator

CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.

Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.

Guide: How Medicare covers telehealth

Enrolled in Medicare (PECOS)

Dr. Clark has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.

It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What Medicare enrollment (PECOS) means

Can order Medicare-covered services

CMS lists Dr. Clark as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.

What this does not show: Can order Medicare-covered services

It does not mean the clinician offers these services directly.

Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.

Guide: What ordering and referring status means

Compared with the same specialty in Fairhope and Alabama

Billing and prescribing volume is not a quality rating.

Medicare Part B services

Close to the middle for clinicians listed under Dermatology in Alabama (2024, 131 clinicians with data). Median for this group: 2,939. Middle half: 1,460 to 4,916.

Too few clinicians listed under Dermatology in Fairhope have Medicare Part B data for 2024 to compare.

Medicare-allowed amount

A lower Medicare-allowed amount than 60% of clinicians listed under Dermatology in Alabama (2024, 131 clinicians with data). Median for this group: $187,306. Middle half: $86,626 to $307,757.

Too few clinicians listed under Dermatology in Fairhope have Medicare Part B data for 2024 to compare.

Paid by Medicare

A lower Medicare payment amount than 60% of clinicians listed under Dermatology in Alabama (2024, 131 clinicians with data). Median for this group: $128,045. Middle half: $63,039 to $226,312.

Too few clinicians listed under Dermatology in Fairhope have Medicare Part B data for 2024 to compare.

Medicare Part D prescriptions

Fewer Part D prescriptions than 65% of clinicians listed under Dermatology in Alabama (2024, 144 clinicians with data). Median for this group: 706. Middle half: 352 to 1,244.

Too few clinicians listed under Dermatology in Fairhope have Medicare Part D data for 2024 to compare.

Part D drug cost

A lower Part D drug cost than 75% of clinicians listed under Dermatology in Alabama (2024, 144 clinicians with data). Median for this group: $206,146. Middle half: $21,506 to $694,711.

Too few clinicians listed under Dermatology in Fairhope have Medicare Part D data for 2024 to compare.

7 active clinicians are listed under Dermatology with a practice address in Fairhope, AL (173 in Alabama).

Addresses are self-reported to NPPES and may be out of date.

Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.

Text: T-MedInfo · Report an error.

Pharma & Medical Device Financial Disclosures

Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments

Open Payments · Program Year 2025
Disclosure Year:

Program year 2025 (payments made January 1 – December 31, 2025): fewer than 11 records totaling $129.75.

Manufacturer Payment Nature Product Type Amount ($)
Bristol Myers Squibb Company
Food and Beverage
Cash or cash equivalent
Sotyktu General $24.35
Pfizer Inc.
Food and Beverage
In-kind items and services
CIBINQO General $23.68
ABBVIE INC.
Food and Beverage
In-kind items and services
RINVOQ General $22.16
ABBVIE INC.
Food and Beverage
In-kind items and services
SKYRIZI General $20.97
ABBVIE INC.
Food and Beverage
In-kind items and services
RINVOQ General $19.44
Bristol Myers Squibb Company
Food and Beverage
Cash or cash equivalent
Sotyktu General $19.15

Source: CMS Open Payments, program year 2025, released June 30, 2026.

Performed Procedures & Service Volume

Services billed to Original Medicare Part B in 2024.

CMS Part B · Data Year 2024
Reporting Year:

CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.

HCPCS Code Services Patients Submitted Charge Medicare Allowed
17003 Destruction of precancer skin growth, 2-14 growths
1,232 187 $6.00 $5.41
99213 Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
418 314 $82.04 $75.66
17000 Destruction of precancer skin growth, 1 growth
313 224 $60.15 $44.09
17110 Destruction of skin growth, 1-14 growths
128 112 $99.97 $86.79
99212 Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
78 73 $50.80 $47.47
17311 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, 1-5 tissue blocks
71 58 $602.33 $513.53
11102 Biopsy of related skin growth, first growth
67 59 $88.09 $70.82
99214 Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
34 32 $116.44 $107.01
12052 Intermediate repair of wound of face, ears, eyelids, nose, lips, or mouth, 2.6-5.0 cm
26 25 $278.98 $138.85
11900 Injection into skin growth, 1-7 growths
23 19 $50.88 $34.90
17261 Destruction of cancer skin growth of trunk, arms, or legs, 0.6-1.0 cm
23 15 $131.46 $92.36
17312 Removal and microscopic exam of growth of head, neck, hands, feet, or genitals, each additional stage, 1-5 tissue blocks
23 21 $363.91 $332.41
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg
23 14 $0.97 $0.93
17004 Destruction of precancer skin growth, 15 or more growths
22 22 $147.84 $135.61
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm
19 16 $158.44 $133.96
17281 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 0.6-1.0 cm
12 11 $160.27 $123.05
11104 Punch biopsy, first skin growth
11 11 $110.69 $94.71

Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits

Submitted charges are billed amounts, not a price quote for your visit.

Medicare Part D Prescribing Profile & Medications

Medicare Part D prescriptions filled, including refills, in 2024.

CMS Part D · Data Year 2024
Prescription Year:
Brand Name Generic Name Prescriptions Day Supply Total Cost Patients
Triamcinolone Acetonide Triamcinolone Acetonide 80 2,277 $559.42 53
Ketoconazole Ketoconazole 65 1,229 $1,143.53 37
Fluorouracil Fluorouracil 53 1,424 $4,907.81 46
Hydrocortisone Hydrocortisone 45 901 $251.72 28
Minocycline Hcl Minocycline Hcl 34 1,560 $435.29 —
Methotrexate Methotrexate Sodium 28 1,119 $224.18 —
Finasteride Finasteride 22 1,590 $200.62 —
Mupirocin Mupirocin 21 314 $163.33 17
Doxycycline Hyclate Doxycycline Hyclate 20 711 $596.76 —
Clobetasol Propionate Clobetasol Propionate 16 515 $890.18 —
Terbinafine Hcl Terbinafine Hcl 15 462 $112.87 —
Famciclovir Famciclovir 15 137 $214.50 —
Fluocinonide Fluocinonide 13 350 $496.88 11
Prednisone Prednisone 12 359 $30.50 —

Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits

Specialties & License Numbers Reported to NPPES

Dermatology Primary Specialty

NUCC Taxonomy Code: 207N00000X

License # reported to NPPES AL 17869

A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.

Check License Status with the State Board License numbers are self-reported to NPPES; T-MedInfo does not confirm them against state records. Current status: Alabama State Board of Medical Examiners.
Look Up on State Board Site

Medicare (PECOS) Enrollment & Ordering Eligibility

Source: CMS PECOS
Medicare FFS Enrollment Status Medicare Enrollment on File
CMS Provider Specialty

PRACTITIONER - DERMATOLOGY

Medicare Enrollment ID

I20110105000255

Enrollment State Jurisdiction

AL

PECOS Control ID

5698960235

Medicare Order & Referring Eligibility
Clinical Lab & Imaging (Part B) Eligible
Durable Medical Equipment (DME) Eligible
Home Health Agency (HHA) Eligible
Power Mobility Devices (PMD) Eligible

Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.

Clinicians Sharing This Practice Address or Phone

Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.

3 listed
Mark Brown , PA

Physician Assistant - Medical

NPI 1578747515

Physician Assistant

NPI 1366420382

Doctor of Medicine (M.D.)

Tia Janicki , PA-C

Physician Assistant

NPI 1972636843

Physician Assistant (Certified)

Career & Practice History

NPI enumerated January 10, 2006.

No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.

No reviews have been published yet. Leave a review.

NPI Administrative Meta

NPI Number: 1548249436
Entity Type:
Individual Provider Physician, Nurse Practitioner, or Solo Healthcare Professional (Type 1 NPI)
Enumeration Date: January 10, 2006
Last Update: July 28, 2010
Sole Proprietor: No

Other Dermatology Specialists in Fairhope

Healthcare providers in Fairhope

Mailing Address

7550 Assunta Ct

Fairhope, AL 365323069

Phone: 2519284944

About This Data NPPES fields (address, phone, specialty, license) are self-reported and may be outdated; Medicare fields follow the CMS dataset named in each section. Correct directly at NPPES.